KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Account Payables (2016 - 2025)

Exact Sciences (EXAS) has disclosed Change in Account Payables for 16 consecutive years, with $48.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 825.36% to $48.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $214.0 million, a 391.62% increase, with the full-year FY2025 number at $214.0 million, up 391.62% from a year prior.
  • Change in Account Payables was $48.9 million for Q4 2025 at Exact Sciences, down from $67.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $105.5 million in Q4 2021 to a low of -$66.0 million in Q1 2022.
  • A 5-year average of $22.9 million and a median of $36.4 million in 2022 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 2308.71% in 2024; the steepest drop was 1010.96% in 2024.
  • Exact Sciences' Change in Account Payables stood at $105.5 million in 2021, then tumbled by 64.83% to $37.1 million in 2022, then decreased by 14.62% to $31.7 million in 2023, then tumbled by 83.33% to $5.3 million in 2024, then soared by 825.36% to $48.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Change in Account Payables are $48.9 million (Q4 2025), $67.1 million (Q3 2025), and $39.4 million (Q2 2025).